Showing results (1-10 of 226) with videos related to
Sort By:
Pageof 23
Antioxidants (Basel, Switzerland)|January 22, 2021
Catalytic Antioxidants in the KidneyYu Ah Hong, Cheol Whee ParkDiabetes & Metabolism Journal|September 13, 2014
Diabetic kidney disease: from epidemiology to clinical perspectivesCheol Whee ParkScientific Reports|May 15, 2024
Xanthine oxidoreductase inhibition ameliorates high glucose-induced glomerular endothelial injury by activating AMPK through the purine salvage pathwayKeum-Jin Yang, Hwajin Park, Yoon-Kyung Chang, et al.Free Radical Biology & Medicine|September 28, 2019
Inhibition of xanthine oxidoreductase protects against contrast-induced renal tubular injury by activating adenosine monophosphate-activated protein kinaseKeum-Jin Yang, Jeong Ho Kim, Yoon Kyung Chang, et al.International Journal of Molecular Sciences|February 25, 2023
Inhibition of Xanthine Oxidase Protects against Diabetic Kidney Disease through the Amelioration of Oxidative Stress via VEGF/VEGFR Axis and NOX-FoxO3a-eNOS Signaling PathwayKeum-Jin Yang, Won Jung Choi, Yoon-Kyung Chang, et al.Kidney Research and Clinical Practice|July 2, 2016
Adenosine monophosphate-activated protein kinase in diabetic nephropathyYaeni Kim, Cheol Whee ParkDiabetes & Metabolism Journal|October 7, 2011
Role of Peroxisome Proliferator-Activated Receptor α in Diabetic NephropathySungjin Chung, Cheol Whee ParkInternational Journal of Molecular Sciences|April 13, 2019
Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney DiseaseYaeni Kim, Cheol Whee ParkThe Korean Journal of Internal Medicine|January 4, 2017
New therapeutic agents in diabetic nephropathyYaeni Kim, Cheol Whee ParkInternational Journal of Molecular Sciences|May 23, 2020
Cilastatin Preconditioning Attenuates Renal Ischemia-Reperfusion Injury via Hypoxia Inducible Factor-1α ActivationYu Ah Hong, So Young Jung, Keum Jin Yang, et al.Pageof 23